Join CBMTG | Print Page | Contact Us | Sign In
Upcoming Webinars

Non-Member Price: $90 + 5% GST
Member Price: FREE

This course has been reviewed and approved by the UBC Division of Continuing Professional Development. This course is an Accredited Group Learning Activity eligible for up to 10.0 MOC Section 1 credits as defined by the Maintenance of Certification program of the Royal College of Physicians and Surgeons of Canada. Each physician should claim only those credits he/she actually spent in the activity.
 
Wednesday, September 27, 2017 
9:00am PT/ 12:00pm ET
CME credit hours: 1.0 credit

Title: The Changing Picture of Transplant Complications: A European Perspective on Veno-Occlusive Disease (VOD)
Speaker: Rafael Duarte, MD, PhD

*Please note this webinar is hosted by one of our sponsors. For more information please click here

Learning Objectives:
1. Learn about the use of revised VOD diagnostic criteria and risk stratification in clinical practice
2. Understand the clinical evidence for efficacy and safety of treatment for VOD
3. Review practical management of patients with sever transplant complications

 


Wednesday, October 18, 2017
9:00am PT/ 12:00pm ET
CME credit hours: 1.0 credit

Title: Ocular Chronic GVHD
Speaker: Vikas Sharma, PhD

Learning Objectives:

TBA


Wednesday, November 1, 2017
9:00am PT/ 12:00pm ET
CME credit hours: 1.0 credit

*Please note this webinar is hosted by one of our sponsors.

Title: TBA
Speaker: TBA

Learning Objectives:
TBA

 


Wednesday, November 15, 2017
10:00am PT/ 1:00pm ET
CME credit hours: 1.0 credit

Title: Quality and Accreditation
Speaker: Denise Brophy

Learning Objectives:

TBA


Wednesday, December 6, 2017 
12:00pm PT/ 3:00pm ET

Title: Invasive Fungal Infections in High-Risk Patietns: When Early Might not be too Early and When Late, Might be too Late
Speaker: TBA

*Please note this webinar is hosted by one of our sponsors. For more information please click here


Learning Objectives:

1. Recognize burden of illness in Canada, risk factors for, and complications of invasive fungal infection (IFI)
2. Outline optimal treatment strategies for the management of IFI while applying latest clinical practice guidelines 
3. Share real life experience with mold-active prophylaxis in high risk patients 
 



This website is sponsored by an unrestricted educational grant from:

Follow CBMTG